Pricing Log in Create free account

Kymera Therapeutics, Inc. (KYMR) vs Twist Bioscience Corporation (TWST)

Kymera Therapeutics, Inc. and Twist Bioscience Corporation are both Biotechnology companies. Kymera Therapeutics, Inc. and Twist Bioscience Corporation are of similar size ($10.8B and $10.1B). Kymera Therapeutics, Inc. grew revenue faster over the last twelve months: 134.8% against 19.2%. Twist Bioscience Corporation has the higher net margin (−31.7% vs −285.3%) and the lower return on invested capital (−30.8% vs −26.7%). Across the 18 metrics below, Twist Bioscience Corporation leads on 11 and Kymera Therapeutics, Inc. on 7.

Valuation

Metric KYMR TWST Biotechnology median
P/E n/m n/m 12.43
P/S 118.40 22.08 10.53
P/B 8.24 21.39 2.24
Price to free cash flow n/m n/m 22.59
EV/EBITDA n/m n/m 0.69
EV/Sales 111.83 21.73 9.92
Earnings yield (2.56%) (1.45%) (34.94%)
Free cash flow yield (1.91%) (1.00%) (23.17%)

Profitability

Metric KYMR TWST Biotechnology median
Gross margin 100.00% 51.97% 68.94%
Operating margin (333.50%) (33.58%) 0.00%
Net margin (285.33%) (31.66%) 0.00%
Free cash flow margin (226.62%) (22.15%) 0.00%
Return on equity (24.15%) (29.59%) (54.09%)
Return on assets (21.58%) (20.78%) (46.84%)
Return on invested capital (26.72%) (30.83%) 0.00%

Growth

Metric KYMR TWST Biotechnology median
Revenue growth (TTM) 134.84% 19.19% 6.72%
EPS growth (last fiscal year) (23.83%) 63.89% 29.36%
Revenue growth, 5-year CAGR 2.87% 33.11% 9.96%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric KYMR TWST Biotechnology median
Debt to equity 0.00 0.03 0.00
Current ratio 10.34 2.67 5.00
Net debt to EBITDA 2.42 1.95 1.01

Dividend

Metric KYMR TWST Biotechnology median
Dividend yield — — 0.40%
Payout ratio — — —

Size

Metric KYMR TWST Biotechnology median
Market cap 10.81b 10.06b 177.44m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack